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Abstract
The International Knockout Mouse Consortium was formed in 2007 to inactivate (“knock-
out”) all protein-coding genes in the mouse genome in embryonic stem cells. Production
and characterization of these mice, now underway, has generated and phenotyped 3,100
strains with knockout alleles. Skin and adnexa diseases are best defined at the gross clinical
level and by histopathology. Representative retired breeders had skin collected from the
back, abdomen, eyelids, muzzle, ears, tail, and lower limbs including the nails. To date,
169 novel mutant lines were reviewed and of these, only one was found to have a relatively
minor sebaceous gland abnormality associated with follicular dystrophy. The B6N(Cg)-
Far2tm2b(KOMP)Wtsi/2J strain, had lesions affecting sebaceous glands with what appeared to
be a secondary follicular dystrophy. A second line, B6N(Cg)-Ppp1r9btm1.1(KOMP)Vlcg/J, had
follicular dystrophy limited to many but not all mystacial vibrissae in heterozygous but not
homozygous mutant mice, suggesting that this was a nonspecific background lesion. We
discuss potential reasons for the low frequency of skin and adnexal phenotypes in mice
from this project in comparison to those seen in human Mendelian diseases, and suggest
alternative approaches to identification of human disease-relevant models.
Introduction
How many genes are involved in the normal ontogeny and physiology of the skin and its
adnexal structures? How do they interact and how are they controlled? These questions, simple
to articulate, have complex answers at best, but are predicated on our knowledge of gene func-
tion and more importantly the pleiotropic functions of genes, which can only be elucidated
though experimentation and particularly through genetic manipulation. Faced with this chal-
lenge, we might initially search major databases such as Mouse Genome Informatics (MGI;
http://www.informatics.jax.org/), Online Mendelian Inheritance in Man (https://www.omim.
org/), or Orphanet (http://www.orpha.net/) and ask whether naturally-occurring or genetically
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engineered mutations show skin and skin-associated phenotypes; this can then be the begin-
ning of a detailed investigation of gene expression, function and control. However, we only
have experimentally-derived functional information for about half (11,973) of the protein-cod-
ing genes in the mouse as assessed by Gene Ontology annotation (MGI statistics; data accessed
19 Feb 2017) of the estimated 24,211 total, and while there are now many electronically
inferred annotations for cellular location, process, and function for many more genes, these
are not reliable predictors of the biological process in which genes may be involved. Critically,
we have some (in many cases sparse) phenotype information from only 3,710 genes in Online
Mendelian Inheritance in Man (accessed 19 Feb 2017). This is therefore greatly enhanced by
gene/phenotype data from genetically variant mouse strains for around 9,493 mouse genes
with human orthologs. The consequence of this is that although the mouse provides a great
deal more functional information than the human, much of the genome remains biologically
featureless, its “dark matter”, and it is only by mutating genes one by one that we can begin to
build up a picture of their involvement in processes and structures, and their patterns of func-
tional pleiotropy which are fundamentally unpredictable from sequence alone. An additional
problem with mutant mice made in pursuit of hypothesis-driven science is that they are often
made on highly variable or undefined genetic backgrounds, often for particular purposes,
without systematic or standardized whole animal phenotyping, making it very difficult to com-
pare phenotypes between mutant mice in any uniform way.
To address this problem on a large-scale basis, an international consortium was formed in
2007 to inactivate (“knockout”) all protein-coding genes in the mouse genome in embryonic
stem cells using multiple gene targeting approaches on a uniform C57BL/6N genetic back-
ground [1, 2]. The second phase of this grand plan, the large-scale production and characteri-
zation of these mice, is now underway [3, 4]. The International Mouse Phenotyping
Consortium was formed in 2011, composed of 17 Institutes across the world in 11 countries
with 5 national funding agencies. This includes the NIH-supported contribution to these
efforts, the Knockout Mouse Phenotyping Program, which consists of 3 groups; 1) The Jackson
Laboratory, The 2) Baylor College of Medicine, The Wellcome Trust Sanger Institute and
MRC Harwell Consortium, and 3) the University of California at Davis, The Toronto Center
for Phenogenomics, Children’s Hospital Oakland Research Institute, and Charles River Labo-
ratories Consortium). These consortia have generated over 5,000 strains of live mice using
these embryonic stem cell lines and have recently transitioned to using CRISPR/Cas9-induced
null alleles. Knockout lines are subjected to detailed, systematic evaluation (phenotyping). A
majority of the phenotyping tests performed as part of these programs focus on physiological
characterization as their primary goal [5]. While this approach generates an enormous amount
of physiological data (clinical pathology, serology/hematology, behavioral data, etc.) [6, 7], his-
topathology, especially when done by highly trained experts focusing on specific organs, can
often make the direct correlation quickly and accurately, as histologic evaluation by patholo-
gists remains the definitive assay in human and veterinary clinical medicine for making most
diagnoses [8, 9]. Furthermore, diseases of some organ systems are only truly defined at the
gross clinical level followed by histopathology, special stains, and other tissue based tests, such
as immunohistochemistry or electron microscopy. The skin, and its adnexa, is one such
system.
While abnormalities of the skin and adnexa (eccrine glands, pilosebaceous unit, hair shaft,
and nails) are easily seen by just looking at the mouse with the naked eye or with magnification
(dissection or scanning electron microscope), detailed histopathology is still necessary to accu-
rately define the abnormality in the skin and some lesions are only apparent microscopically.
A primary high-throughput phenotyping strategy concentrates on wide coverage of a large
Skin phenotypes in KOMP mutant mice
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number of parameters in a large number of mice and consequently is designed to pick up rela-
tively clear-cut examples of phenodeviance.
Prior to the initiation of the current international efforts, both Lexicon and Deltagen under-
took large-scale systematic mutagenesis and phenotyping projects, of which Lexicon’s used
systematic histopathology as a routine phenotyping tool (see [10] for discussion) and gener-
ated histopathological analyses on nearly 5,000 mutant strains. Detailed descriptions of these
strains are now in the process of being published in the literature [11, 12].
More recently, the Sanger Mouse Genetics Program reported a preliminary general histopa-
thology workup of 50 randomly selected knockout lines yielding 2 with skin phenotypes, using
single samples of dorsal skin from two males and two female mice [13]. This was comple-
mented by a “special skin workup” as part of an extended primary phenotyping pipeline [14].
The histopathology protocol involved collecting one piece of dorsal skin, fixing, and process-
ing it routinely to create hematoxylin and eosin stained slides. Nearly 800 mutant mouse skin
samples were collected from 562 mutant lines in this high-throughput protocol. One and
sometimes two slides with two or three serial sections of dorsal skin from one mouse in the
study were provided. Mice were approximately 15 weeks of age. Only 23 lines (4.1%) had some
sort of skin phenotype while all the others were normal, implying that many of the genes inac-
tivated had no function in the skin; at least not evident from this screening protocol.
The International Mouse Phenotyping Consortium database currently (accessed 17 Febru-
ary 2017) shows that overall 2.22% of 3,199 lines show abnormalities of skin morphology and
5.35% of 2,971, abnormalities of the adnexa. This group reported no abnormalities of skin
physiology in its database to date. A search of the Europhenome database, which overlaps with
the International Mouse Phenotyping Consortium, shows 12 genes with annotations on skin
morphology and physiology (excluding nociception; 27) of 563 genotypes derived from these-
mutagenesis efforts (2.1%). The low number of skin phenotypes in these samples contrasts
the frequent reporting of skin and adnexal phenotypes both in human Mendelian diseases and
in the gathered data of MGI. Detailed examination of the MGI database shows that 1,069 of
9,045 targeted genes with phenotypes are annotated to either skin morphology or phenotypes;
approximately 12%. In OMIM, 1,314/3,710 gene entries with phenotypic annotations are
annotated to “abnormality of skin, HP:000095” or its children in the Human Phenotype Ontol-
ogy database (35%) [15]. Assuming that we might expect skin and adnexal phenotypes in both
humans and mice to result from loss of function of the same gene, the key question is where
are the missing phenotypes? Even considering the exceptionally detailed phenotyping carried
out in clinical practice, this is a large discrepancy. One possibility is that in the mouse, loss of
function genes involved in the development or function of the skin and adnexa might be
embryonic or neonatal lethal. However, this may also be an issue of detection; either through
skewed phenotyping (i.e. not focused on the skin or not reported) or failure to detect pheno-
types. There are projects associated with the US KnockOut Mouse Program that examine
embryonic and perinatal lethality, yet none of them look beyond gross skin phenotype as
reasons for early mortality [4]. From the reasoning above, we believe this problem can be
addressed through careful targeted skin phenotyping.
The Jackson Laboratory is one of three sites in the United States generating knockout
mutant mice. Histopathology is an optional parameter in the phenotyping pipeline, and thus
is not performed and/or reported universally from individual centers. To better address find-
ing skin lesions, representative retired breeder mice were received, histology was done on
skin and nails from multiple sites, and slides were screened by a veterinary pathologist special-
izing in phenotyping skin mutants. Candidate models were subsequently reviewed by a physi-
cian pathologist specializing in dermatopathology. In so doing 169 novel mutant lines were
Skin phenotypes in KOMP mutant mice
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reviewed and of those only one was found to have a relatively minor sebaceous gland
abnormality.
Results
Skin, hair follicles, and nail units of both sexes were screened for lesions in 169 novel mutant
lines of knockout mice generated at JAX (Table 1). Of these 116 (68.6%) were homozygous
and 61 (36.1%) were heterozygous mutant mice. Four lines had both heterozygous and homo-
zygous mice screened (2.4%). Of the heterozygous mice, 62.3% were pre-wean lethal and
11.5% were sub-viable, which is defined as yielding fewer than half of the expected number of
homozygotes from an intercross (<12.5%). For these strains no homozygous mutant mice
were evaluated. A total of 743 (2.2 average per line and sex) mice were necropsied and the skin
and adnexa were evaluated histologically. Nine lines (two females and three males for hetero-
zygotes only and three females and one male for homozygotes only) had only one sex
evaluated.
Nonspecific, sporadic lesions were found in many of the mice in this study. Most com-
monly these were ruptured hair follicles with hair shaft fragments free in the dermis or hypo-
dermal fat layer surrounded by a variety of inflammatory cell types, usually neutrophils
around the hair shaft and a layer of macrophages (trichogranuloma, Fig 1). These were often
solitary and not consistently found in all the mice within a mutant line, which was a primary
criterion to differentiate these lesions from gene mutation associated phenotypes. Other mice
had follicular dystrophy consistent with C57BL/6 alopecia and dermatitis, a low frequency,
strain-specific skin disease resembling human central centrifugal cicatricial alopecia [16].
Mice with null mutations in their fatty acyl CoA reductase 2 (Far2tm2b(KOMP)Wtsi/2J) gene
were found to consistently develop focal alopecia as adults on the dorsal skin extending distally
from the base of the ears (Fig 2). Histologically, in areas where the skin appeared to be rela-
tively normal there were minor lesions affecting the pilosebaceous and Meibomian (eyelids)
glands that could be easily over-looked. Other modified sebaceous glands (Zymbal, clitoral, or
preputial glands) were not examined in this study. The sebaceous glands superficially appeared
to be normal but within the sebaceous duct the sebocytes became brightly eosinophilic and,
when these holocrine cells ruptured, their secretion remained present and clumped. By con-
trast, normal sebocytes were slightly basophilic with fine, uniformly sized vacuoles in their
cytoplasm. When the normal cells ruptured there was no evidence of their cytoplasmic content
within the follicular infundibulum or on the skin surface (Fig 3). In areas of alopecia, the epi-
dermis was mildly acanthotic with orthokeratotic hyperkeratosis associated with areas of follic-
ular dystrophy and rupture and an associated foreign body inflammatory response that would
lead to follicular scarring, a form of cicatricial alopecia (Fig 4). Skin surface lipidomic and
time course studies are in progress to better define these changes. Further, non-integument
phenotypes affecting lipid metabolism, behavior, immunity, and the cardiovascular system
have been reported for this strain, and can be found on the IMPC database website (http://
www.mousephenotype.org/data/genes/MGI:2687035#section-associations).
Heterozygous mutant mice for the protein phosphatase 1, regulatory subunit 9B
(Ppp1r9btm1.1(KOMP)Vlcg/J) gene had between one and five vibrissae hair shafts undergoing
degenerative changes (follicular dystrophy) in each of three females and two males examined.
Each section contained 10–15 vibrissae follicles (Fig 5). Only mystacial vibrissae were affected,
not the periorbital or lower leg vibrissae. No other hair types were affected. This change was
not found in two female and two male homozygous mutants suggesting that this was a nonspe-
cific background lesion, as vibrissae follicular dystrophy was also seen occasionally in many
mouse lines but only in one or two follicles and not consistently in all vibrissae in any section.
Skin phenotypes in KOMP mutant mice
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Table 1. KOMP lines evaluated. Clinical summary of 169 KOMP strains screened for skin, hair, and nail abnormalities.
No. Strain JR # Mutant Allele No.
Mice








1 B6N(Cg) 24041 4933427D14Riktm1.1(KOMP)Vlcg/J 2 138/161 HET
B6N(Cg) 24041 4933427D14Riktm1.1(KOMP)Vlcg/J 2 138/161 HET
2 B6N(Cg) 24902 Acsf2tm1.1(KOMP)Vlcg/J 1 218 HOM
B6N(Cg) 24902 Acsf2tm1.1(KOMP)Vlcg/J 3 218/222 HOM
3 C57BL/6NJ 25814 Adad1em1J/J 2 272/325 HET X
C57BL/6NJ 25814 Adad1em1J/J 2 308/337 HET X
4 C57BL/6NJ 25475 Adad2em1J/J 2 193/199 HET
C57BL/6NJ 25475 Adad2em1J/J 2 196/199 HET
5 B6N(Cg) 18592 Adora2btm1.1(KOMP)Vlcg/J 2 282 HOM
B6N(Cg) 18592 Adora2btm1.1(KOMP)Vlcg/J 2 165/223 HET
6 B6N(Cg) 18561 Ahrrtm1b(KOMP)Wtsi/J 2 41/138 HOM
B6N(Cg) 18561 Ahrrtm1b(KOMP)Wtsi/J 2 41/138 HOM
7 B6N(Cg) 25117 Akip1tm1.1(KOMP)Vlcg/J 2 183 /189 HOM
B6N(Cg) 25117 Akip1tm1.1(KOMP)Vlcg/J 2 183/189 HOM
8 B6N(Cg) 24334 Akr1b8tm1.1(KOMP)Vlcg/J 2 125 HOM
B6N(Cg) 24334 Akr1b8tm1.1(KOMP)Vlcg/J 2 125 HOM
9 B6N(Cg) 24656 Anapc15tm1.1(KOMP)Vlcg/J 2 125/139 HET X
B6N(Cg) 24656 Anapc15tm1.1(KOMP)Vlcg/J 2 166 HET X
10 B6N(Cg) 21510 Ap4e1tm1b(KOMP)Wtsi/J 2 266 HOM
B6N(Cg) 21510 Ap4e1tm1b(KOMP)Wtsi/J 2 198/359 HOM
11 B6N(Cg) 22304 Arhgef10tm1.1(KOMP)Vlcg/J 1 95 HOM
B6N(Cg) 22304 Arhgef10tm1.1(KOMP)Vlcg/J 3 95/99 HOM
12 B6N(Cg) 18607 Arrdc1tm1.1(KOMP)Vlcg/J 3 180/213 HET
B6N(Cg) 18607 Arrdc1tm1.1(KOMP)Vlcg/J 1 180 HET
13 B6N(Cg) 18657 Arsktm1b(KOMP)Wtsi/J 2 254 HOM
B6N(Cg) 18657 Arsktm1b(KOMP)Wtsi/J 1 254 HOM
14 B6N(Cg) 18660 Asb10tm2b(KOMP)Wtsi/J 2 173 HOM
B6N(Cg) 18660 Asb10tm2b(KOMP)Wtsi/J 2 120 HOM
15 B6N(Cg) 22101 Asf1atm1b(KOMP)Wtsi/2J 2 320/385 HET X
B6N(Cg) 22101 Asf1atm1b(KOMP)Wtsi/2J 2 362/386 HET X
16 B6N(Cg) 22305 Atriptm1b(KOMP)Wtsi/J 2 340 HET X
B6N(Cg) 22305 Atriptm1b(KOMP)Wtsi/J 2 346 HET X
17 B6N(Cg) 24979 Bbs7tm1b(EUCOMM)Wtsi/J 2 191/192 HET X
B6N(Cg) 24979 Bbs7tm1b(EUCOMM)Wtsi/J 2 177/192 HET X
18 B6N(Cg) 21751 Btg2tm1b(KOMP)Mbp/2J 2 223 HOM
B6N(Cg) 21751 Btg2tm1b(KOMP)Mbp/2J 2 204/352 HOM
19 B6N(Cg) 18653 Bzw2tm1b(KOMP)Mpb/J 2 186 HOM
B6N(Cg) 18653 Bzw2tm1b(KOMP)Mpb/J 2 226 HOM
20 B6N(Cg) 22307 C1qatm1b(EUCOMM)Wtsi/3J 2 308 HOM
B6N(Cg) 22307 C1qatm1b(EUCOMM)Wtsi/3J 2 308 HOM
21 B6N(Cg) 18562 C1qtnf5tm1.1(KOMP)Vlcg/J 2 380/472 HOM
B6N(Cg) 18562 C1qtnf5tm1.1(KOMP)Vlcg/J 2 443 HOM
22 B6N(Cg) 22098 C3tm1.1(KOMP)Vlcg/J 2 128/219 HOM
B6N(Cg) 22098 C3tm1.1(KOMP)Vlcg/J 2 128/225 HOM
23 B6N(Cg) 21282 C9tm1(KOMP)Vlcg/J 1 198/206 HET
B6N(Cg) 21282 C9tm1(KOMP)Vlcg/J 2 269 HET
24 B6N(Cg) 22418 Cacna2d3tm1b(KOMP)Wtsi/J 2 239 HOM
B6N(Cg) 22418 Cacna2d3tm1b(KOMP)Wtsi/J 2 239 HOM
25 B6N(Cg) 23393 Casttm1.1(KOMP)Vlcg/2J 2 111/171 HOM
B6N(Cg) 23393 Casttm1.1(KOMP)Vlcg/2J 2 111/171 HOM
26 B6N(Cg) 18111 Ccd20tm1(KOMP)Vlcg/J 2 337/339 HET X
(Continued)
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Table 1. (Continued)
No. Strain JR # Mutant Allele No.
Mice








27 B6N(Cg) 24349 Ccl26tm1.1(KOMP)Vlcg/J 3 216/232/ 251 HOM
B6N(Cg) 24349 Ccl26tm1.1(KOMP)Vlcg/J 1 157 HOM
28 B6N(Cg) 22016 Cd33tm1.1(KOMP)Vlcg/J 4 147/321 HOM
B6N(Cg) 22016 Cd33tm1.1(KOMP)Vlcg/J 4 176/321 HOM
29 B6N(Cg) 22335 Ceacam16tm1.1(KOMP)Wtsi/J 4 100/207/
227/285
HOM
B6N(Cg) 22335 Ceacam16tm1.1(KOMP)Wtsi/J 4 100/207/
273/285
HOM
30 B6N(Cg) 18836 Cenpotm1b(KOMP)Mbp/J 2 313/379 HET X
B6N(Cg) 18836 Cenpotm1b(KOMP)Mbp/J 2 354/379 HET X
31 B6N(Cg) 22819 Cers5tm2b(KOMP)Mbp/J 2 206 HOM
B6N(Cg) 22819 Cers5tm2b(KOMP)Mbp/J 2 206 HOM
32 B6N(Cg) 18603 Chn1tm1.1(KOMP)Vlcg/J 2 244/247 HOM
B6N(Cg) 18603 Chn1tm1.1(KOMP)Vlcg/J 2 244/246 HOM
33 B6N(Cg) 25118 Chp2tm1b(KOMP)Mbp/J 3 149/210/ 211 HET
B6N(Cg) 25118 Chp2tm1b(KOMP)Mbp/J 2 210/211 HET
34 B6N(Cg) 23317 Chtf18tm1b(KOMP)Wtsi/J 2 300 HET X
B6N(Cg) 23317 Chtf18tm1b(KOMP)Wtsi/J 2 300 HET X
35 B6N(Cg) 18631 Cinptm1.1(KOMP)Vlcg/J 2 126/136 HET X
B6N(Cg) 18631 Cinptm1.1(KOMP)Vlcg/J 4 131/135/ 136 HET X
36 B6N(Cg) 18587 Cited4tm1.1(KOMP)Vlcg/J 2 140/183 HOM
B6N(Cg) 18587 Cited4tm1.1(KOMP)Vlcg/J 2 140/183 HOM
37 B6N(Cg) 23666 Cldn19tm1.1(KOMP)Vlcg/J 2 230/324 HOM
B6N(Cg) 23666 Cldn19tm1.1(KOMP)Vlcg/J 2 230/255 HOM
38a B6N(Cg) 18604 Col18a1tm1.1(KOMP)Vlcg/J 2 193/208 HET
B6N(Cg) 18604 Col18a1tm1.1(KOMP)Vlcg/J 2 191/208 HET
38b B6N(Cg) 18604 Col18a1tm1.1(KOMP)Vlcg/J 2 322/350 HOM
B6N(Cg) 18604 Col18a1tm1.1(KOMP)Vlcg/J 2 322/350 HOM
39 B6N(Cg) 21485 Cptm1b(KOMP)Wtsi/J 2 184/326 HOM
B6N(Cg) 21485 Cptm1b(KOMP)Wtsi/J 2 271/326 HOM
40 B6N(Cg) 22015 Crymtm1b(KOMP)Wtsi/J 2 161/198 HOM
B6N(Cg) 22015 Crymtm1b(KOMP)Wtsi/J 2 161/198 HOM
41 B6N(Cg) 22096 Cyb5d1tm1.1(KOMP)Vlcg/J 3 323/354 HOM
B6N(Cg) 22096 Cyb5d1tm1.1(KOMP)Vlcg/J 1 355 HOM
42 B6N(Cg) 24035 Cyb5d2tm1.1(KOMP)Wtsi/J 2 203 HOM
B6N(Cg) 24035 Cyb5d2tm1.1(KOMP)Wtsi/J 2 203 HOM
43 B6N(Cg) 22777 Dbf4tm1b(KOMP)Wtsi/J 2 137/155 HET X
B6N(Cg) 22777 Dbf4tm1b(KOMP)Wtsi/J 2 178 HET X
44 B6N(Cg) 27202 Dbn1tm1a(KOMP)Wtsi/J 2 274 HET X
B6N(Cg) 27202 Dbn1tm1a(KOMP)Wtsi/J 2 200/241 HET X
45 B6N(Cg) 23604 Dcpstm1b(EUCOMM)Hmgu/J 2 249 HET X
B6N(Cg) 23604 Dcpstm1b(EUCOMM)Hmgu/J 2 258 HET X
46 B6N(Cg) 18632 Dnajb3tm1.1(KOMP)Vlcg/J 2 209/240 HOM
B6N(Cg) 18632 Dnajb3tm1.1(KOMP)Vlcg/J 2 202/240 HOM
47 B6N(Cg) 18580 Dnajb7tm1.1(KOMP)Vlcg/J 1 250 HOM
B6N(Cg) 18580 Dnajb7tm1.1(KOMP)Vlcg/J 2 268 HOM
48 B6N(Cg) 18597 Dnajb12tm1.1(KOMP)Vlcg/J 2 156/243 HOM
49 B6N(Cg) 18616 Dnajc5gtm1.1(KOMP)Vlcg/J 2 301 HOM
B6N(Cg) 18616 Dnajc5gtm1.1(KOMP)Vlcg/J 2 164 HOM
50 B6N(Cg) 18637 Dnajc14tm1.1(KOMP)Vlcg/J 4 136/177 HOM
B6N(Cg) 18637 Dnajc14tm1.1(KOMP)Vlcg/J 4 117/177/ 352 HOM
(Continued)
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Table 1. (Continued)
No. Strain JR # Mutant Allele No.
Mice








51 B6N(Cg) 18633 Dnajc16tm1.1(KOMP)Vlcg/J 1 122 HET X
B6N(Cg) 18633 Dnajc16tm1.1(KOMP)Vlcg/J 2 122 HET X
52 B6N(Cg) 21508 Dnase1l2tm1.1(KOMP)Wtsi/J 2 326 HOM
53 B6N(Cg) 26437 Enox1tm1.1(KOMP)Vlcg/J 3 239 HET
B6N(Cg) 26437 Enox1tm1.1(KOMP)Vlcg/J 1 266 HET
54 B6N(Cg) 23489 Ermp1tm1.1(KOMP)Vlcg/J 4 167/201/ 220 HOM
B6N(Cg) 23489 Ermp1tm1.1(KOMP)Vlcg/J 4 170/173/ 201 HOM
55 B6N(Cg) 24660 Espnltm1b(KOMP)Wtsi/2J 2 180 HOM
B6N(Cg) 24660 Espnltm1b(KOMP)Wtsi/2J 2 145 HOM
56 C57BL/6NJ 25733 Exoc4em1J/J 4 121/123 HET X
C57BL/6NJ 25733 Exoc4em1J/J 2 121/123 HET X
57 B6N(Cg) 18622 Exosc8tm1.1(KOMP)Vlcg/J 2 379 HET X
B6N(Cg) 18622 Exosc8tm1.1(KOMP)Vlcg/J 2 429 HET X
58 B6N(Cg) 18705 Fam161atm1b(KOMP)Wtsi/2J 2 209 HOM
B6N(Cg) 18705 Fam161atm1b(KOMP)Wtsi/2J 2 253/316 HOM
59 B6N(Cg) 22011 Far2tm2b(KOMP)Wtsi/2J 2 184 HOM dystrophy hypo-plasia
B6N(Cg) 22011 Far2tm2b(KOMP)Wtsi/2J 2 172/184 HOM dystrophy hypo-plasia
60 B6N(Cg) 22097 Foxo3tm1.1(KOMP)Vlcg/J 2 148 HOM
B6N(Cg) 22097 Foxo3tm1.1(KOMP)Vlcg/J 2 226 HOM
61 B6N(Cg) 21486 Ghrtm1b(KOMP)Wtsi/3J 2 304/337 HET
B6N(Cg) 21486 Ghrtm1b(KOMP)Wtsi/3J 2 304/337 HET
62 B6N(Cg) 19459 Ghrhrtm1.1(KOMP)Vlcg/2J 1 292 HOM
B6N(Cg) 19459 Ghrhrtm1.1(KOMP)Vlcg/2J 2 141 HOM
63 B6N(Cg) 18595 Ghsrtm1.1(KOMP)Vlcg/J 4 143/153/ 370 HOM
B6N(Cg) 18595 Ghsrtm1.1(KOMP)Vlcg/J 4 156/370 HOM
64 B6N(Cg) 18643 Gipc3tm1b(KOMP)Wtsi/J 2 208 HOM
B6N(Cg) 18643 Gipc3tm1b(KOMP)Wtsi/J 2 208 HOM
65 B6N(Cg) 18558 Glycam1tm1.1(KOMP)Vlcg/J 1 180 HOM
B6N(Cg) 18558 Glycam1tm1.1(KOMP)Vlcg/J 1 180 HOM
66 B6N(Cg) 24058 Gnb5tm1.1(KOMP)Vlcg/J 2 174/185 HET X
B6N(Cg) 24058 Gnb5tm1.1(KOMP)Vlcg/J 2 186 HET X
67 B6N(Cg) 18594 H1fxtm1.1(KOMP)Vlcg/J 2 189 HOM
B6N(Cg) 18594 H1fxtm1.1(KOMP)Vlcg/J 2 186/195 HOM
68 C57BL/6NJ 25319 Heyltm1b(KOMP)Wtsi/J 2 215 HOM
C57BL/6NJ 25319 Heyltm1b(KOMP)Wtsi/J 2 215 HOM
69 B6N(Cg) 24947 Hfe2tm1b(KOMP)Wtsi/J 2 168/197 HOM
B6N(Cg) 24947 Hfe2tm1b(KOMP)Wtsi/J 2 197/198 HOM
70 B6N(Cg) 24981 Hsf2tm1b(KOMP)Wtsi/3J 2 172 HOM
B6N(Cg) 24981 Hsf2tm1b(KOMP)Wtsi/3J 2 172 HOM
71 B6N(Cg) 22782 Hspb1tm1(KOMP)Vlcg/2J 2 188 HET
72 B6N(Cg) 18619 Hspb2tm1.1(KOMP)Vlcg/J 4 262/263/ 386 HOM
B6N(Cg) 18619 Hspb2tm1.1(KOMP)Vlcg/J 4 262/263/ 386 HOM
73 B6N(Cg) 18618 Hspb3tm1.1(KOMP)Vlcg/J 2 144/199 HOM
B6N(Cg) 18618 Hspb3tm1.1(KOMP)Vlcg/J 2 144/199 HOM
74 B6N(Cg) 18617 Htr1atm1.1(KOMP)Vlcg/J 2 345 HOM
B6N(Cg) 18617 Htr1atm1.1(KOMP)Vlcg/J 2 137/308 HOM
75 B6N(Cg) 24347 Htr1dtm1.1(KOMP)Vlcg/2J 2 165 HOM
B6N(Cg) 24347 Htr1dtm1.1(KOMP)Vlcg/2J 2 165/226 HOM
76 B6N(Cg) 18615 Htr3btm1.1(KOMP)Vlcg/J 2 299 HOM
B6N(Cg) 18615 Htr3btm1.1(KOMP)Vlcg/J 2 299 HOM
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77 B6N(Cg) 23606 Ift88tm1.1(KOMP)Vlcg/J 2 350 HET X
B6N(Cg) 23606 Ift88tm1.1(KOMP)Vlcg/J 2 349/350 HET X
78a B6N(Cg) 21516 Igsf11tm1b(KOMP)Wtsi/J 1 297 HET
B6N(Cg) 21516 Igsf11tm1b(KOMP)Wtsi/J 3 287/300 HET
78b B6N(Cg) 21516 Igsf11tm1b(KOMP)Wtsi/J 2 280/351 HOM
B6N(Cg) 21516 Igsf11tm1b(KOMP)Wtsi/J 2 280 HOM
79 B6N(Cg) 22303 Il12rb2tm1.1(KOMP)Vlcg/J 4 168/206/ 264 HOM
B6N(Cg) 22303 Il12rb2tm1.1(KOMP)Vlcg/J 4 168/206 HOM
80 B6N(Cg) 22005 Il24tm1.1(KOMP)Vlcg/2J 4 64/165/194/
214
HOM
B6N(Cg) 22005 Il24tm1.1(KOMP)Vlcg/2J 4 64/165/194/
214
HOM
81 B6N(Cg) 22388 Il6sttm1b(KOMP)Mbp/J 2 180/210 HOM
B6N(Cg) 22388 Il6sttm1b(KOMP)Mbp/J 2 210 HOM
82 B6N(Cg) 18655 Irf8tm1b(KOMP)Wtsi/J 2 195 HOM
B6N(Cg) 18655 Irf8tm1b(KOMP)Wtsi/J 2 171/195 HOM
83 B6N(Cg) 24055 Jam2tm1.1(KOMP)Mbp/J 2 140 HOM
B6N(Cg) 24055 Jam2tm1.1(KOMP)Mbp/J 2 140 HOM
84 B6N(Cg) 26066 Jmjd8tm1.1(KOMP)Vlcg/J 3 269 HOM
B6N(Cg) 26066 Jmjd8tm1.1(KOMP)Vlcg/J 1 269 HOM
85 B6N(Cg) 22821 Juptm1.1(KOMP)Vlcg/J 2 109/143 HET X
B6N(Cg) 22821 Juptm1.1(KOMP)Vlcg/J 2 107/143 HET X
86 B6N(Cg) 21140 Kcnh3tm1.1(KOMP)Vlcg/2J 1 186 HOM
B6N(Cg) 21140 Kcnh3tm1.1(KOMP)Vlcg/2J 2 186/288 HOM
87 B6N(Cg) 23603 Kif1btm1b(KOMP)Wtsi/2J 2 319 HET X
B6N(Cg) 23603 Kif1btm1b(KOMP)Wtsi/2J 2 322 HET X
88 B6N(Cg) 22085 Kif26btm2b(KOMP)Wtsi/J 2 323/446 HET X
B6N(Cg) 22085 Kif26btm2b(KOMP)Wtsi/J 2 327/446 HET X
89 B6N(Cg) 25381 Klk14tm1.1(KOMP)Vlcg/J 2 115/161 HOM
B6N(Cg) 25381 Klk14tm1.1(KOMP)Vlcg/J 2 115/152 HOM
90 B6N(Cg) 23318 Krt17tm1.1(KOMP)Vlcg/2J 2 297/304 HET
B6N(Cg) 23318 Krt17tm1.1(KOMP)Vlcg/2J 2 297/304 HET
91 B6N(Cg) 25383 Krt9tm1.1(KOMP)Vlcg/J 2 210 HOM
B6N(Cg) 25383 Krt9tm1.1(KOMP)Vlcg/J 2 210 HOM
92 B6N(Cg) 25518 Lipntm1.1(KOMP)Vlcg/J 4 188/189/ 195 HOM
93 B6N(Cg) 18563 Loxl1tm1.1(KOMP)Vlcg/J 4 112/133/ 147 HET
B6N(Cg) 18563 Loxl1tm1.1(KOMP)Vlcg/J 2 110 HET
94 B6N(Cg) 22094 Lpar6tm1.1(KOMP)Vlcg/J 2 172/226 HOM
B6N(Cg) 22094 Lpar6tm1.1(KOMP)Vlcg/J 2 172/213 HOM
95 B6N(Cg) 23021 Lrrc15tm1b(KOMP)Wtsi/J 1 183 HOM
B6N(Cg) 23021 Lrrc15tm1b(KOMP)Wtsi/J 1 48 HOM
96 B6N(Cg) 23024 Mdktm1.1(KOMP)Mbp/J 2 193 HOM
B6N(Cg) 23024 Mdktm1.1(KOMP)Mbp/J 2 193 HOM
97a B6N(Cg) 22092 Mmp8tm1(KOMP)Vlcg/J 2 213 HET
97b B6N(Cg) 22092 Mmp8tm1.1(KOMP)Vlcg/J 2 232/273 HOM
B6N(Cg) 22092 Mmp8tm1.1(KOMP)Vlcg/J 2 245/273 HOM
98 B6N(Cg) 18635 Mrps25tm1.1(KOMP)Vlcg/J 2 303 HET X
B6N(Cg) 18635 Mrps25tm1.1(KOMP)Vlcg/J 2 303/364 HET X
99 B6N(Cg) 24673 Myo7btm1b(EUCOMM)Hmgu/J 2 237/240 HOM
B6N(Cg) 24673 Myo7btm1b(EUCOMM)Hmgu/J 2 236/237 HOM
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100 B6N(Cg) 23599 Nat1tm1.1(KOMP)Vlcg/J 2 142/152 HOM
B6N(Cg) 23599 Nat1tm1.1(KOMP)Vlcg/J 2 142/157 HOM
101 B6N(Cg) 18575 Ncaldtm1.1(KOMP)Vlcg/J 3 230/315 HOM
B6N(Cg) 18575 Ncaldtm1.1(KOMP)Vlcg/J 3 230/310/ 408 HOM
102 B6N(Cg) 18577 Nefhtm1.1(KOMP)Vlcg/J 1 230 HOM
B6N(Cg) 18577 Nefhtm1.1(KOMP)Vlcg/J 1 230 HOM
103 B6N(Cg) 18697 Nemftm1b(EUCOMM)Hmgu/J 2 78 HET X
B6N(Cg) 18697 Nemftm1b(EUCOMM)Hmgu/J 2 78 HET X
104 B6N(Cg) 24185 Nestm1b(KOMP)Wtsi/J 2 139/140 HOM
B6N(Cg) 24185 Nestm1b(KOMP)Wtsi/J 2 162/170 HOM
105 B6N(Cg) 18638 Nmrk2tm1.1(KOMP)Vlcg/J 2 172/177 HOM
B6N(Cg) 18638 Nmrk2tm1.1(KOMP)Vlcg/J 2 177/180 HOM
106 B6N(Cg) 18645 Nrcamtm2e.1(KOMP)Wtsi/J 2 242/275 HOM
B6N(Cg) 18645 Nrcamtm2e.1(KOMP)Wtsi/J 2 242/275 HOM
107 B6N(Cg) 24899 Nsun7tm1.1(KOMP)Vlcg/J 3 183/190 HET
B6N(Cg) 24899 Nsun7tm1.1(KOMP)Vlcg/J 1 183 HET
108 B6N(Cg) 24233 Nxntm1b(EUCOMM)Wtsi/J 2 232/236 HET X
B6N(Cg) 24233 Nxntm1b(EUCOMM)Wtsi/J 2 236 HET X
109 B6N(Cg) 24036 Orc1tm1b(KOMP)Wtsi/J 2 185 HET X
B6N(Cg) 24036 Orc1tm1b(KOMP)Wtsi/J 2 185/206 HET X
110 B6N(Cg) 22338 Osmtm1b(KOMP)Wtsi/J 4 198/270/
358/376
HOM
B6N(Cg) 22338 Osmtm1b(KOMP)Wtsi/J 4 198/270/ 358 HOM
111 B6N(Cg) 23058 Parp8tm1.1(KOMP)Wtsi/J 2 202 HOM
B6N(Cg) 23058 Parp8tm1.1(KOMP)Wtsi/J 2 202 HOM
112 B6N(Cg) 21613 Parp16tm1.1(KOMP)Mbp/2J 2 288 HOM
B6N(Cg) 21613 Parp16tm1.1(KOMP)Mbp/2J 2 265 HOM
113 B6N(Cg) 22341 Pcsk5tm1b(KOMP)Mbp/J 2 306/321 HET X
B6N(Cg) 22341 Pcsk5tm1b(KOMP)Mbp/J 2 346 HET X
114 B6N(Cg) 24330 Pnmttm1.1(KOMP)Vlcg/J 4 120/140/
152/182
HOM
B6N(Cg) 24330 Pnmttm1.1(KOMP)Vlcg/J 3 140/182 HOM
115a B6N(Cg) 18609 Ppp1r9btm1.1(KOMP)Vlcg/J 4 139/282 HET vibrissa
B6N(Cg) 18609 Ppp1r9btm1.1(KOMP)Vlcg/J 2 139/330 HET vibrissa
115b B6N(Cg) 18609 Ppp1r9btm1.1(KOMP)Vlcg/J 2 321 HOM
B6N(Cg) 18609 Ppp1r9btm1.1(KOMP)Vlcg/J 2 114/137 HOM
116 B6N(Cg) 22099 Preptm1b(KOMP)Wtsi/J 2 328/350 HET X
B6N(Cg) 22099 Preptm1b(KOMP)Wtsi/J 2 350 HET X
117a B6N(Cg) 18576 Prom2tm1.1(KOMP)Vlcg/J 3 89 HET
B6N(Cg) 18576 Prom2tm1.1(KOMP)Vlcg/J 1 89 HET
117b B6N(Cg) 18576 Prom2tm1.1(KOMP)Vlcg/J 2 403 HOM
B6N(Cg) 18576 Prom2tm1.1(KOMP)Vlcg/J 2 437 HOM
118 B6N(Cg) 24025 Psen1tm1.1(KOMP)Vlcg/J 2 225/240 HET X
B6N(Cg) 24025 Psen1tm1.1(KOMP)Vlcg/J 2 240 HET X
119 B6N(Cg) 23667 Pycr1tm1.1(KOMP)Vlcg/J 2 165/251 HOM
B6N(Cg) 23667 Pycr1tm1.1(KOMP)Vlcg/J 2 165/251 HOM
120 B6N(Cg) 22387 Rab5atm1b(KOMP)Wtsi/J 4 222/230 HOM
B6N(Cg) 22387 Rab5atm1b(KOMP)Wtsi/J 4 222/227/ 230 HOM
121 B6N(Cg) 22389 Rab24tm1(KOMP)Wtsi/J 2 179 HET
B6N(Cg) 22389 Rab24tm1(KOMP)Wtsi/J 2 243 HET
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122 B6N(Cg) 23422 Rab27btm1b(KOMP)Wtsi/J 2 127/129 HOM
B6N(Cg) 23422 Rab27btm1b(KOMP)Wtsi/J 2 133/159 HOM
123 B6N(Cg) 24188 Rab34tm1b(EUCOMM)Hmgu/J 2 328 HET X
B6N(Cg) 24188 Rab34tm1b(EUCOMM)Hmgu/J 2 328 HET X
124 B6N(Cg) 23664 Rab36tm1b(KOMP)Wtsi/J 2 96/255 HOM
B6N(Cg) 23664 Rab36tm1b(KOMP)Wtsi/J 2 96/255 HOM
125 B6N(Cg) 23059 Rab43tm1.1(KOMP)Vlcg/J 2 130 HOM
B6N(Cg) 23059 Rab43tm1.1(KOMP)Vlcg/J 2 130 HOM
126 B6N(Cg) 26882 Rabac1tm1.1(KOMP)Vlcg/J 2 118 HOM
B6N(Cg) 26882 Rabac1tm1.1(KOMP)Vlcg/J 2 118 HOM
127 B6N(Cg) 25849 Rbpjtm1b(EUCOMM)Hmgu/J 2 298 HET X
B6N(Cg) 25849 Rbpjtm1b(EUCOMM)Hmgu/J 2 255 HET X
128 B6N(Cg) 18572 Resp18tm1.1(KOMP)Vlcg/J 1 231 HOM
B6N(Cg) 18572 Resp18tm1.1(KOMP)Vlcg/J 2 231 HOM
129 B6N(Cg) 24674 Rhbdl2tm1b(KOMP)Wtsi/J 2 138 HOM
B6N(Cg) 24674 Rhbdl2tm1b(KOMP)Wtsi/J 2 138 HOM
130 B6N(Cg) 21750 Rilpl2tm1b(KOMP)Wtsi/J 4 150/198/ 287 HOM
B6N(Cg) 21750 Rilpl2tm1b(KOMP)Wtsi/J 4 242/287/ 295 HOM
131 B6N(Cg) 21511 Rnf10tm1b(KOMP)Wtsi/J 2 222 HOM
B6N(Cg) 21511 Rnf10tm1b(KOMP)Wtsi/J 2 228 HOM
132 B6N(Cg) 26493 Rps6kl1tm1.1(KOMP)Vlcg/J 2 242 HOM
B6N(Cg) 26493 Rsp6kl1tm1.1(KOMP)Vlcg/J 2 242 HOM
133 B6N(Cg) 23136 Sdhatm2b(KOMP)Wtsi/2J 2 343/393 HET X
B6N(Cg) 23136 Sdhatm2b(KOMP)Wtsi/2J 2 393/396 HET X
134 B6N(Cg) 24038 Sgtatm1b(KOMP)Mbp/J 2 250/254 HET
B6N(Cg) 24038 Sgtatm1b(KOMP)Mbp/J 2 250 HET
135 B6N(Cg) 21142 Sh3tc2tm1b(KOMP)Wtsi/J 2 221 HOM
B6N(Cg) 21142 Sh3tc2tm1b(KOMP)Wtsi/J 1 227 HOM
136 B6N(Cg) 23511 Ska2tm1b(KOMP)Wtsi/J 2 228 HET X
B6N(Cg) 23511 Ska2tm1b(KOMP)Wtsi/J 2 231 HET X
137 B6N(Cg) 23414 Slc25a35tm1.1(KOMP)Vlcg/J 2 179 HOM
B6N(Cg) 23414 Slc25a35tm1.1(KOMP)Vlcg/J 2 179 HOM
138a B6N(Cg) 22780 Sorbs2tm1(KOMP)Mbp/J 1 86 HET
B6N(Cg) 22780 Sorbs2tm1(KOMP)Mbp/J 3 86/199 HET
138b B6N(Cg) 22780 Sorbs2tm1.1(KOMP)Mbp/J 1 159 HOM
B6N(Cg) 22780 Sorbs2tm1.1(KOMP)Mbp/J 2 159/160 HOM
139 B6N(Cg) 23020 Sox18tm1.1(KOMP)Vlcg/J 2 178/226 HOM
B6N(Cg) 23020 Sox18tm1.1(KOMP)Vlcg/J 2 161/165 HOM
140 B6N(Cg) 26095 Spag4tm1.1(KOMP)Mbp/J 2 161 HOM
B6N(Cg) 26095 Spag4tm1.1(KOMP)Mbp/J 1 59 HOM
141 B6N(Cg) 18820 Sptssatm1b(KOMP)Wtsi/J 2 287/292 HET X
B6N(Cg) 18820 Sptssatm1b(KOMP)Wtsi/J 2 327 HET X
142 B6N(Cg) 24184 Srd5a3tm1b(EUCOMM)Wtsi/J 2 258/265 HET X
B6N(Cg) 24184 Srd5a3tm1b(EUCOMM)Wtsi/J 2 265 HET X
143 B6N(Cg) 21115 Stag3tm1e.1(KOMP)Wtsi/2J 1 234 HOM
B6N(Cg) 21115 Stag3tm1e.1(KOMP)Wtsi/2J 2 104/275 HOM
144 B6N(Cg) 18611 Stk16tm1.1(KOMP)Vlcg/J 2 105 HET X
B6N(Cg) 18611 Stk16tm1.1(KOMP)Vlcg/J 2 66/105 HET X
145 B6N(Cg) 18611 Stk16tm1.1(KOMP)Vlcg/J 2 39 HOM
B6N(Cg) 18611 Stk16tm1.1(KOMP)Vlcg/J 2 39 HOM
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146 B6N(Cg) 22781 Stx16tm1b(KOMP)Wtsi/J 1 301 HOM
B6N(Cg) 22781 Stx16tm1b(KOMP)Wtsi/J 2 301/320 HOM
147 B6N(Cg) 22784 Sycp3tm1(KOMP)Vlcg/J 2 110 HET
B6N(Cg) 22784 Sycp3tm1(KOMP)Vlcg/J 2 183 HET
148 B6N(Cg) 22784 Sycp3tm1.1(KOMP)Vlcg/J 4 197/214/
274/279
HOM
B6N(Cg) 22784 Sycp3tm1.1(KOMP)Vlcg/J 4 165/202/ 274 HOM
149 B6N(Cg) 23665 Syn3tm1.1(KOMP)Vlcg/J 2 267/270 HOM
B6N(Cg) 23665 Syn3tm1.1(KOMP)Vlcg/J 2 267/270 HOM
150 B6.129S1 24694 Tgm2tm1Rmgr/J 2 230/234 HOM
B6.129S1 24694 Tgm2tm1Rmgr/J 2 203/234 HOM
151 B6N(Cg) 24406 Timm22tm1b(KOMP)Wtsi/J 2 181/192 HET X
B6N(Cg) 24406 Timm22tm1b(KOMP)Wtsi/J 2 193 HET X
152 B6N(Cg) 18639 Timp3tm1.1(KOMP)Vlcg/J 3 210/278/ 292 HOM
B6N(Cg) 18639 Timp3tm1.1(KOMP)Vlcg/J 1 210 HOM
153 B6N(Cg) 18629 Tmem136tm1.1(KOMP)Vlcg/J 2 254/274 HOM
B6N(Cg) 18629 Tmem136tm1.1(KOMP)Vlcg/J 2 187/274 HOM
154 B6N(Cg) 23060 Tmem151btm1b(KOMP)Wtsi/J 4 219/221/ 288 HOM
B6N(Cg) 23060 Tmem151btm1b(KOMP)Wtsi/J 4 202/288 HOM
155 B6N(Cg) 26542 Tpcn1tm1.1(KOMP)Vlcg/J 3 174 HOM
B6N(Cg) 26542 Tpcn1tm1.1(KOMP)Vlcg/J 1 174 HOM
156 B6N(Cg) 21752 Tpgs2tm1.1(KOMP)Vlcg/J 2 156 HOM
B6N(Cg) 21752 Tpgs2tm1.1(KOMP)Vlcg/J 2 156 HOM
157 B6N(Cg) 18606 Tprntm1.1(KOMP)Vlcg/J 2 270 HOM
B6N(Cg) 18606 Tprntm1.1(KOMP)Vlcg/J 2 141/293 HOM
158 B6N(Cg) 18553 Trip13tm1.1(KOMP)Vlcg/J 4 181/196/ 239 HOM
B6N(Cg) 18533 Trip13tm1.1(KOMP)Vlcg/J 4 41/181/321 HOM
159 B6N(Cg) 21483 Tspan18tm1.1(KOMP)Vlcg/J 2 263 HOM
B6N(Cg) 21483 Tspan18tm1.1(KOMP)Vlcg/J 2 263 HOM
160 C57BL/6NJ 26909 Ttll10em1J/J 2 200/229 HOM
C57BL/6NJ 26909 Ttll10em1J/J 2 196/229 HOM
161 B6N(Cg) 22817 Ube2ctm1.1(KOMP)Wtsi/J 2 249/270 HET X
B6N(Cg) 22817 Ube2ctm1.1(KOMP)Wtsi/J 2 287 HET X
162 B6N(Cg) 24027 Ube2mtm1.1(KOMP)Wtsi/2J 2 484 HET X
B6N(Cg) 24027 Ube2mtm1.1(KOMP)Wtsi/2J 2 484 HET X
163 B6N(Cg) 23019 Vsig8tm1.1(KOMP)Mbp/J 1 116 HOM
B6N(Cg) 23019 Vsig8tm1.1(KOMP)Mbp/J 1 44 HOM
164 B6N(Cg) 23660 Zbtb4tm1.1(KOMP)Vlcg/J 2 267 HOM
B6N(Cg) 23660 Zbtb4tm1.1(KOMP)Vlcg/J 2 144/267 HOM
165 B6N(Cg) 18620 Zdhhc11tm1.1(KOMP)Vlcg/J 4 127 HET
166 B6N(Cg) 24091 Zfp346tm1.1(KOMP)Vlcg/J 2 194/202 HET X
B6N(Cg) 24091 Zfp346tm1.1(KOMP)Vlcg/J 2 194/219 HET X
167 B6N(Cg) 23023 Zfp42tm1b(KOMP)Mbp/J 2 151 HOM
B6N(Cg) 23023 Zfp42tm1b(KOMP)Mbp/J 2 145 HOM
168 B6N(Cg) 24057 Zfp961tm1.1(KOMP)Mbp/J 2 179/226 HOM
B6N(Cg) 24057 Zfp961tm1.1(KOMP)Mbp/J 2 179/226 HOM
169a C57BL/6NJ 22366 Zzef1tm2(KOMP)Vlcg/J 2 198/206 HET
C57BL/6NJ 22366 Zzef1tm2(KOMP)Vlcg/J 2 269 HET
169b B6N(Cg) 22366 Zzef1tm2.1(KOMP)Vlcg/J 1 103 HOM
B6N(Cg) 22366 Zzef1tm2.1(KOMP)Vlcg/J 2 95/352 HOM
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The skin and nail sections from almost all of the mice in these studies were clinically and
histologically normal.
Discussion
We have investigated the apparent deficiency of skin and adnexal phenotypes in a random set
of strains from a systematic, genome-wide, knockout study using histopathological phenotyp-
ing. We report here that numbers detected confirm an earlier study [14] which also showed
low numbers of detectable skin phenotypes, suggesting that ascertainment is not the cause of
the “missing phenotypes”.
Of over 100 homozygous mutants screened, only one line, Far2tm2b(KOMP)Wtsi/2J, had
lesions affecting sebaceous glands with what appeared to be a secondary follicular dystrophy,
which probably progresses to a form of cicatricial alopecia as seen with a number of other
mouse mutations with abnormalities of the sebaceous glands [17]. A rare autosomal recessive
neurological disease without hair abnormalities was reported for humans with mutations in
FAR1 [18]. While the biochemistry of these two proteins, FAR1 and FAR2, is known no disease
is currently associated with mutations in FAR2 in humans (http://omim.org/entry/616156?
search=Far2&highlight=far2). However, Far2 transcripts were reported in the eyelid and skin,
presumably localized in the Meibomian and sebaceous glands, respectively [19]. Information
obtained from phenotyping these mice will be useful to help assess sebaceous gland abnormali-
ties in humans as not all genes that are expressed in sebaceous glands result in sebaceous gland
abnormalities or clinically obvious hair problems, such as mouse null mutations in Soat1 [20,
21]. Detailed studies are in progress to define that pathogenesis of the follicular dystrophy and
to match it with a specific human disease in these Far2 mutant mice.
A second line, Ppp1r9btm1.1(KOMP)Vlcg/J, had follicular dystrophy limited to many but not all
vibrissae in heterozygous but not homozygous mutant mice suggesting this was a nonspecific
background problem. A targeted mutant mouse line made for this gene (Ppp1r9btm1Jfe) was
reported to only have neurological abnormalities [22, 23]. As the vibrissae are an important
somatosensory organ in the mouse [24] this structure should be carefully evaluated in such
phenotyping studies.
The International Mouse Phenotyping Consortium has provided a unique, internally con-
sistent dataset with genome-wide coverage and has yielded a great deal of valuable information
on gene function. At the outset anticipation was high that systematic creation of null mice for
all known protein coding genes would yield large amounts of information on the pathobiology
of human disease. The high frequency of embryonic and neonatal lethal lines [4], consistent
with previous estimates [6], was not a surprise, but potentially limits the value of these mice for
Table 1. (Continued)
No. Strain JR # Mutant Allele No.
Mice










Strain not listed as B6N(Cg)
HET Heterozygous mutant mice
HOM Homozygous mutant mice
Normal skin and adnexa
Lesion in skin or adnexa
X Prenatal lethal or subviable phenotype
Clinically normal phenotype
https://doi.org/10.1371/journal.pone.0180682.t001
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Fig 1. Incidental lesions were found scattered throughout the skin samples in many lines. Incidental
lesions were not consistently found in all mice of a line. Lesions included solitary tail skin hair follicle with
infundibular plugging (A-C). Truncal hair follicle infundibular plugging, rupture below the level of the
sebaceous gland, follicle filled with neutrophils and surrounded by neutrophils and macrophages (D-F).
Sporadic skin lesions found in many mice examined included isolated, one or two, ruptured hair follicles in the
dermis where the free hair shaft fragments were engulfed by granulomas and surrounded by neutrophils (G-I).
Hematoxylin and eosin stain, bar size indicated in each figure.
https://doi.org/10.1371/journal.pone.0180682.g001
Skin phenotypes in KOMP mutant mice
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detailed investigation of adult phenotypes and diseases which will require carefully designed
conditional strategies.
The relatively low frequency of skin phenotypes in the International Mouse Phenotyping
Consortium mice found in this and an earlier study [11] was surprising given the frequency
expected from global surveys of MGI and OMIM discussed above. The histopathological sur-
vey presented here was very detailed focusing on the skin, and we believe this supports the
assertion that the “missing phenotypes” are not due to lack of ascertainment, at least in the ran-
dom sample selected. The remaining possibilities are that genes involved in skin morphogene-
sis and physiology are overrepresented in those essential for embryogenesis, the C57BL6N
background is failing to show phenotypes, or that the complete removal of gene function in
the mouse knockouts have more severe functional consequences than the point mutations,
regulatory lesions, and insertions/deletions (indels) that constitute most disease-causing muta-
tions in humans. Protein truncating variants which provide the greatest likelihood of complete
functional loss (“knockouts”) are very rare in the human population [25].
In the current study, 74% of the heterozygous lines were pre-wean lethal or sub-viable as
homozygotes (that were not examined) presenting the possibility that mutants having skin
phenotypes might also be embryonic essential genes. While it is possible to argue that essential
genes should never show up as disease genes in a population due to negative selection, there is
increasing evidence that essential genes are often ‘disease genes”–i.e. carry mutations that are
associated with abnormal or disease phenotypes. This is by no means a settled conclusion
Fig 2. A B6N(Cg)-Far2tm2b(KOMP)Wtsi/2J mutant (left) and wildtype (right) mouse. Both are 15 week old
females. Note the alopecia extending distally from the base of the ears.
https://doi.org/10.1371/journal.pone.0180682.g002
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however. The relationship between gene essentiality and disease association is discussed in
detail in Cooper et al. [25].
Studies conducted around a decade ago, based on a limited gene set, suggested that mouse
genes that are essential—i.e., genes related to more severe phenotypes in mouse, are more
likely to be human disease genes, but that embryonic lethals were less likely [26]. However, a
Fig 3. Sebaceous gland changes in fatty acyl CoA reductase 2 mutant mice. Most late stage anagen hair
follicles in B6N(Cg)-Far2tm2b(KOMP)Wtsi/2J mutant mice, as in this 184 day old male, were relatively normal and
produced a normal hair shaft (A). However, the sebaceous glands were mildly hypoplastic with brightly
eosinophilic mature sebocytes that did not immediately rupture as they entered the infundibulum (C). As in
other mouse mutations that cause hypoplasia of sebaceous glands, the hair shafts in these mice did not exit
the follicular ostium resulting in perforation of the root sheaths, release of the hair shaft into the dermis, and an
inflammatory reaction (B). This healed by follicular scarring, or cicatricial alopecia. By contrast, aged and sex
matched B6N(Cg) controls rarely exhibited ruptured follicles (D). Sebaceous glands varied in size with the hair
cycle, which was normal, and sebocytes had light pink cytoplasm that becomes very pale as the cells matured
and abruptly ruptured into the duct. (E). Hematoxylin and eosin stain, bar size indicated in each figure.
https://doi.org/10.1371/journal.pone.0180682.g003
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more recent study strongly suggested that about 30% of human disease genes (from OMIM)
have a mouse ortholog with a lethal knockout phenotype (673/1965) [27]. The discrepancies
here reflect to an extent the methodology used to calculate the association and the inclusion or
exclusion of genes with no phenotypic data in the study by Park et al. [26]. This association
will certainly stand further scrutiny now that more data are available, but does not explain why
the IMPC/KOMP strains show fewer skin phenotypes than the bulk of the loss-of-function
allele carrying strains in MGI. Core analysis carried out on Ingenuity™ using the lists of lethal
essential genes from supplementary table 3 of Dickinson et al. [4] shows no significant enrich-
ment of annotations to dermatological disease or skin development, mitigating against the
Fig 4. Follicular dystrophy in fatty acyl CoA reductase 2 mutant mice. In areas of alopecia, the B6N(Cg)-
Far2tm2b(KOMP)Wtsi/2J mutant skin was mildly acanthotic and orthokeratotic, most likely secondary to the
abnormal secretions of the sebaceous glands. The infundibulum was mildly dilated (A, B). Follicles with
follicular dystrophy (C, D) and with pigment cast (E) were identified occasionally to frequently. Such ruptured
follicles with granulomatous inflammation eventually lead to follicular scarring, a form of cicatricial alopecia.
Hematoxylin and eosin stain, bar size indicated in each figure.
https://doi.org/10.1371/journal.pone.0180682.g004
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possibility that genes associated with skin disease are overrepresented in the essential segment
of the genome. A working conclusion, therefore, is that either there is a problem with the strain
background in this resource showing full expressivity of mutations affecting the skin, or that
we have so far insufficient coverage of the genome using high-resolution phenotyping to
account for the “missing phenotypes” from the International Mouse Phenotyping Consortium
program. Of concern is the observation that most human disease associated mutations are
hypomorphic alleles which, in the event of lethal homozygosity of complete KOs, are much
more likely to present a phenotype compatible with survival. The potential for missing these
with a complete loss of function strategy is significant, especially when examining completely
novel genes where there are no existing experimental or inferred annotations. The power of
looking for skin phenotypes using a strategy such as that developed by Beutler et al. [28]
using ENU mutagenesis is very persuasive. Currently Mutagenetix (https://mutagenetix.
utsouthwestern.edu/home.cfm), accessed 1 Mar 2017) shows 49 genes with skin associated
Fig 5. Vibrissae dystrophy in some protein phosphatase 1, regulatory subunit 9B mice. B6N(Cg)-Ppp1r9btm1.1(KOMP)Vlcg/J, had
follicular dystrophy limited to many but not all mystacial vibrissae in heterozygous but not homozygous mutant mice suggesting this is an
incidental, albeit relatively frequent lesion. Boxed areas are enlarged as indicated by the arrows. Pigment casts are identified in all dystrophic
hair follicles (B, F, and H). Hematoxylin and eosin stain, bar size indicated in each figure.
https://doi.org/10.1371/journal.pone.0180682.g005
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phenotypes recovered as phenotypic mutations from a total of 262 phenotyped genes (119 of
498 mapped mutations) and should be considered in the future along with full characterization
of spontaneous and ENU generated mutations in large collections.
Materials and methods
Generation of mutant mice
Embryonic stem cell lines. Initially mice included in the program were produced from
embryonic stem cell lines acquired from repositories (https://www.komp.org/ or http://www.
eummcr.org/). These resources comprised two major allele types, the Velocigene “definitive
null” allele produced by the Regeneron Corporation (Vlcg) [1] and the “knockout first, condi-
tional ready” design produced by the Wellcome Trust Sanger Centre and partners (Sanger)
[2]. The Vlcg alleles delete the entire coding sequence of the target gene, including all introns,
while inserting a LacZ reporter cassette. The neo resistance cassette is flanked by loxP sites for
removal by cre-recombinase. The Sanger allele is a multifunctional design. In its native form,
the strong splice acceptor typically generates a null allele. When bred to Flp-expressing mice,
the entire 5’ LacZ and neo cassette are removed leaving a loxP-flanked critical exon for condi-
tional mutagenesis. When bred to cre-recombinase transgenic mice, this allele is converted
into a “definitive null” which retains the 5’ LacZ cassette and removes the critical exon and neo
marker.
All animal work was approved by The Jackson Laboratory Animal Care and Use Commit-
tee (approval number 07005 "Mouse Models for Dermatology Research”).
Generating live mice. Following importation at The Jackson Laboratory, clones are
injected into blastocyst hosts and resulting chimeras are bred to C57BL/6NJ (STOCK#5304)
or C57BL/6NJ-Tyrem3J/GrsrJ (STOCK#21999; to select for coat color transmission) inbred
mice (see Table 1) to assure isogenicity of the resource. Germline transmitting (GLT) clones
are quality confirmed (both Vlcg and Sanger) for targeting. Following GLT, mice are bred to
congenic cre-recombinase transgenic mice (B6N.Cg-Tg(Sox2-cre)1Amc/J; STOCK#14094) to
remove the neo cassette and to generate a definitive null allele, generating the tm1.1 allele (Vlcg
and non-conditional Sanger clones) and tm1b allele (from conditional-ready Sanger clones).
Four lines were generated by CRISPR/Cas9 mutagenesis, using standard approaches [29] to
generate small deletions in the early part of the transcript. These mice are expanded, quality
control-confirmed, and intercrossed to generate knockout mice. Approximately 30% of lines
display lethality or sub-lethality (defined as yielding less than 12.5% homozygous mice) [4].
For these strains, heterozygous mice were phenotyped. For other strains, homozygous breeder
pairs established for colony maintenance used in this study when they became retired breeders
to maximize chances of finding adult onset diseases.
Systematic analysis of mutant mice
Animal logistics. Two female and two male retired breeder mice were provided from The
Jackson Laboratory knockout mouse production program (Table 1). Homozygous lethal
embryos and perinatal lethal mouse lines were specifically excluded from these studies. In
these cases, heterozygous animals were aged and evaluated. All lines, whether Vlcg definitive
null or Sanger conditional-ready mice were evaluated post-cre excision, which removed the
neo cassette and heterologous promoter and in the case of Sanger alleles also removing the crit-
ical exon to create a definitive null allele (Vlcg tm1.1 and Sanger tm1b). All mice had skin, hair,
and nails collected (see below).
Necropsy procedures, slide generation, and histopathologic analyses. As the skin is
anatomically and molecularly distinct throughout the body in both mice and humans [30, 31]
Skin phenotypes in KOMP mutant mice
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and diseases can be restricted to specific anatomic sites, skin was collected from several areas.
As dorsal and ventral trunk skin are histologically similar in the mouse, they were collected
with other anatomically identifiable tissues and put into respective cassettes: 1) dorsal skin and
ear skin; 2) ventral skin, eyelid skin, muzzle skin; 3) digits to include the foot pads and nail
unit; and 4) cross and longitudinal sections of the tail. This allows for evaluation of all major
hair follicle types, mucocutaneous junctions, the nail unit, as well as the footpad (including
eccrine glands) [32]. Detailed protocols on skin removal, orientation, and processing are
described elsewhere [33]. Tissues were fixed in Fekete’s acid-alcohol-formalin solution. Sec-
tions were stained with hematoxylin and eosin (H&E) for routine screening.
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